Nancy Stuart, Chief Operating Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 12,096 shares at $8.33 ($101K) on 2023-02-15, disclosed to the SEC on 2023-02-16.
Seasonal sale ($101k) by Chief Operating Officer — this insider has traded CNCE in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.33 | 6,048 | $50K | 50.0% |
| 2 | $8.33 | 6,048 | $50K | 50.0% |
| Total | $8.33 avg | 12,096 | $101K | 100% |
| Filing → |
| CNCE | SELL | 2022-02-16 | $19K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |
| CNCE | SELL | 2021-02-17 | $44K | — | Filing → |